Analysis of Methamphetamine-Related Deaths: A Retrospective Cross-Sectional Study

Arif Garbioğlu1, Hacı Altay2

  • 1Department of Forensic Medicine, Faculty of Medicine, Zonguldak Bulent Ecevit University, Zonguldak, Turkey.

Drug and Alcohol Review
|August 17, 2026
PubMed
Abstract

Insights

Methamphetamine-related deaths are rising globally. In Turkey, this study found most fatalities were accidental, primarily due to methamphetamine toxicity, with a significant male demographic and high rates of polydrug use.

Area of Science:

  • Forensic Toxicology
  • Public Health
  • Medicolegal Science

Background:

  • Global increase in methamphetamine use and mortality.
  • Limited existing forensic data from Turkey.

Purpose of the Study:

  • Investigate demographic, toxicological, and medicolegal aspects of methamphetamine deaths in Turkey.
  • Provide crucial data to inform public health strategies.

Main Methods:

  • Retrospective cross-sectional autopsy study.
  • Analysis of 30 confirmed methamphetamine-positive cases from 2015-2025.
  • Examination of demographic, toxicological, and medicolegal findings.

Main Results:

  • Average age of 33.4 years, with 90% male cases.
  • Peak detection in 2023, with accidental death and methamphetamine toxicity as leading causes.
  • Cardiovascular disease as the cause for natural deaths; polydrug use in 56.7% of cases.

Conclusions:

  • Methamphetamine deaths in Turkey align with international trends.
  • Highlights the increasing medicolegal and public health challenges posed by stimulant use.
  • Emphasizes the need for targeted interventions and further research.

Related Concept Videos

Phase II Reactions: Methylation Reactions01:17

Phase II Reactions: Methylation Reactions

Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...